Today Sonnet (NASDAQ: SONN) quickly soars above 70% on increasing 100 million shares along with Tiziana (TLSA) and ElectroCore (ECOR) who announce valuable news to investors.
July has brought not much change for SONN except this day while stock futures surge slowly. Biotech stocks are rising now steeply together with tech stocks like Pinterest (PINS), Jumia (JMIA), and Facebook (FB) due to speculative news around the COVID-19 vaccine.
Sonnet has no earnings yet because of low revenue caused by insufficient product range. The stock is still penny giving a viable opportunity to gambling investors who believe in ‘good risk’. Losing small cash will bring no serious consequences to the portfolio.
CEO and Editor in Chief.
Living in the era of dynamic tech change Asan decided to stay tuned in changes that make any person find comfort and adapt to new devices. Furthermore, gaming became his passion for spending leisure time with his close ones. Although, he has a degree in Business Administration (majoring Finance) writing for technology and as well as finance has been one of the precious aspects of his life